Cover Image
Read Now

Use of botulinum toxin-A in pain associated with neuromuscular disorders

This report evaluates the use of Botulinum toxin type-A in the control of pain associated with neuromuscular disorders. The efficacy, safety, and appropriate patient selection criteria for BTX treatment of neuromuscular disorders were evaluated based on data published in the peer-reviewed literature

Bibliographic Details
Corporate Authors: Minnesota Health Technology Advisory Committee, Minnesota Department of Health
Format: eBook
Language:English
Published: St. Paul, MN Minnesota Dept. of Health 2001, 2001
Series:Minnesota health technology assessments
Subjects:
Muscle Spasticity / Drug Therapy
Neuromuscular Diseases / Drug Therapy
Botulinum Toxins, Type A / Therapeutic Use
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01428nam a2200277 u 4500
001 EB000943244
003 EBX01000000000000000736834
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
245 0 0 |a Use of botulinum toxin-A in pain associated with neuromuscular disorders  |h Elektronische Ressource  |c Minnesota Health Technology Advisory Committee 
260 |a St. Paul, MN  |b Minnesota Dept. of Health  |c 2001, 2001 
300 |a 1 online resource 
505 0 |a Includes bibliographical references 
653 |a Muscle Spasticity / drug therapy 
653 |a Neuromuscular Diseases / drug therapy 
653 |a Botulinum Toxins, Type A / therapeutic use 
710 2 |a Minnesota  |b Health Technology Advisory Committee 
710 2 |a Minnesota  |b Department of Health 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Minnesota health technology assessments 
500 |a "Created: July 2001." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK52505  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a This report evaluates the use of Botulinum toxin type-A in the control of pain associated with neuromuscular disorders. The efficacy, safety, and appropriate patient selection criteria for BTX treatment of neuromuscular disorders were evaluated based on data published in the peer-reviewed literature 

Similar Items